Author

F. Barei

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cumulative Disease Control with Upadacitinib in Moderate-to-Severe Atopic Dermatitis-A 52-Week Multicenter Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

INTRODUCTION Fixed-timepoint endpoints may not fully capture longitudinal treatment benefit in atopic dermatitis (AD). We evaluated the 52-week real-world effectiveness and safety of upadacitinib, focusing on cumulative disease control. METHODS This multicenter retrospective analysis of prospectively collected LANDSC...

L. Potestio, M. Bianco, L. Mastorino et al. · Dermatologic Therapy · 0 citations

Oct 2026

Upadacitinib for the Management of Atopic Dermatitis in Patients Aged ≥60 Years: A Long-Term Multicenter Real-World Study.

BACKGROUND Atopic dermatitis (AD) in the elderly is increasing worldwide and presents therapeutic challenges due to age-related comorbidities that often contraindicate systemic therapies. Although oral Janus kinase (JAK) inhibitors show efficacy in moderate-to-severe AD, older adult patients are underrepresented in cli...

E. Ippoliti, N. Gori, G. Coscarella et al. · Dermatitis · 0 citations

Review Open access Oct 2026

The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach.

Chronic spontaneous urticaria (CSU) is a heterogeneous mast cell-driven disease associated with a substantial burden on patients' quality of life. Although most patients achieve disease control with guideline-recommended therapies, a relevant proportion remains refractory, highlighting important unmet needs. This narra...

A. Giménez-Arnau, F. Barei, A. Salman · Italian journal of dermatolo... · 0 citations